Andrew Wang, MD

Andrew Wang, MD, is a prominent figure in the field of radiation oncology, currently serving as the Vice Chair of Translational Research and Commercialization and a Professor with Tenure at UT Southwestern Medical Center. He holds the A. Kenneth Pye Professorship in Cancer Research and is a member of the Harold C. Simmons Comprehensive Cancer Center.

Education and Training

• Medical Degree: Dr. Wang earned his MD from the Harvard-MIT Health Sciences and Technology Program at Harvard Medical School.
• Internship: He completed an internship in internal medicine at St. Luke’s-Roosevelt Hospital Center in New York.
• Residency: He underwent clinical training in radiation oncology through the Harvard Radiation Oncology Program.
• Postdoctoral Fellowship: Dr. Wang also completed a postdoctoral fellowship at the Massachusetts Institute of Technology (MIT).

Career Highlights

• Dr. Wang joined UT Southwestern in 2021 after serving as an Assistant Professor at the University of North Carolina, where he rose to tenured full professor status.
• His research focuses on integrating advances in engineering, particularly nanotechnology, with clinical applications in oncology. He has been continuously funded by the National Institutes of Health (NIH) and the Department of Defense since 2013, leading to over 40 patent applications related to his work.

Research Contributions

Dr. Wang's innovative research includes:

• Development of antigen-capturing nanoparticles, which aim to enhance immunotherapy responses for cancer patients.
• Exploration of new technologies for treating autoimmune diseases by applying insights gained from cancer treatment methodologies.

Honors and Memberships

• Elected as a Fellow of the American Association for the Advancement of Science (AAAS).
• Member of the American Society for Clinical Investigation (ASCI).
• Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

Dr. Wang's work exemplifies a commitment to advancing cancer treatment through translational research, bridging the gap between laboratory discoveries and clinical applications.123